Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy

Presentations include data for WVE-N531 that provide first clinical evidence of a potential therapeutic for DMD accessing satellite cells, which are important for potential muscle regeneration ...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Anne Marie Li Kwai Cheung ,Kate Rausch ,Andrew Hart ,Alicia Suter ,Kuldeep Singh ,Abbie Maguire ,Chelley Casey ,Wave Life Sciences Nasdaq ,Wave Life Sciences Ltd ,Exchange Commission ,Wave Life Sciences ,Twitter ,Community Contact ,Clinical Research Poster ,Linkedin ,Nasdaq ,Muscular Dystrophy Association ,Life Sciences ,Dystrophy Association ,Scientific Conference ,Chief Development Officer ,Wave Life ,Skeletal Muscles ,Non Human Primates ,Oligonucleotides Yield High Levels ,Exon Skipping ,Dystrophin Protein Restoration ,Preclinical Models ,Senior Scientist ,Clinical Evidence ,Satellite Cell Targeting ,Senior Director ,Trials Poster ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,